Organogenesis Holdings Inc. (ORGO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 656.5M |
| Enterprise Value | 695.67M |
| P/E Ratio | -2.24 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.52 |
| Price/Book Ratio | 0.82 |
| Enterprise/Revenue | 0.56 |
| Enterprise/EBITDA | -54.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.2 |
| Operating Margin | -0.06 |
AD
Management Effectiveness
| Return On Assets | -0.22 |
| Return On Equity | -0.24 |
Income Statement
| Revenue | 563.03M |
| Revenue/Share | 3.55 |
| Gross Profit | 425.51M |
| EBITDA | 73.91M |
| Net Income | 37.03M |
| Diluted EPS | 0.15 |
Balance Sheet
| Total Cash | 46.1M |
| Total Cash/Share | 0.36 |
| Total Debt | 66.95M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 3.52 |
| Book Value Per Share | 2.24 |
Price History
| 52-Week Change | -58.84 |
| 52-Week High | 7.08 |
| 52-Week Low | 1.54 |
| Moving Average 50 Days | 2.32 |
| Moving Average 200 Days | 3.3 |
Statistics
| Average Volume | 857,553 |
| Shares Outstanding | 128.67M |
| % Held by Institutions | 48.99 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
